- Filed
- Jul 17, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Jul 10, 2024 | 61.91M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2024 | 37.35M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 4.9M sh |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2024 | $216.85K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$906.13K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $26.58K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $34.01K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$5.07M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2023 | −$1.05M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $2.45M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $2.7M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $10.39M |
| Current Liabilities restated | Q1 2024 · Dec 31, 2023 | $11.18M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $10.39M |
| Total Liabilities restated | Q1 2024 · Dec 31, 2023 | $11.18M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $4.23M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $5.38M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $5.32M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $10.13M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2024 | −$0.16 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.36 |
| Eps Basic restated | Q1 2024 · Mar 31, 2024 | −$0.16 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.36 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $1.69M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $1.85M |
| Net Income restated | Q1 2024 · Mar 31, 2024 | −$6.16M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$1.74M |
| Operating Income restated | Q1 2024 · Mar 31, 2024 | −$5.65M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$1.43M |
| Gross Profit restated | Q1 2024 · Mar 31, 2024 | −$824.07K |
| Gross Profit restated | Q1 2024 · Mar 31, 2023 | $414.73K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $1.19M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $524.58K |
| Revenue restated | Q1 2024 · Mar 31, 2024 | $369.1K |
| Revenue | Q1 2024 · Mar 31, 2023 | $939.31K |
| Capex | Q1 2024 · Mar 31, 2023 | $15K |